PLX - Protalix BioTherapeutics, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-19,2429,1994,364
Cost of Revenue-15,2318,398730
Gross Profit-4,0118013,634
Operating Expenses
Research Development-28,05923,60819,025
Selling General and Administrative-12,30510,3568,279
Non Recurring----
Total Operating Expenses-55,59542,36228,034
Operating Income or Loss--36,353-33,163-23,670
Income from Continuing Operations
Total Other Income/Expenses Net--48,9233,987-3,612
Earnings Before Interest and Taxes--36,353-33,163-23,670
Interest Expense--572-3,364-3,549
Income Before Tax--85,276-29,176-27,282
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--85,276-29,176-27,282
Non-recurring Events
Discontinued Operations---18985,319
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--85,276-29,36558,037
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--85,276-29,36558,037